Chargement en cours...
Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans
Glucocorticoids (GC) are used for the treatment of inflammatory diseases, including various forms of arthritis. However, their use is limited, amongst others, by adverse effects on bone. The Wnt and bone formation inhibitor sclerostin was recently implicated in the pathogenesis of GC-induced osteopo...
Enregistré dans:
| Publié dans: | Endocr Connect |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Bioscientifica Ltd
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6612066/ https://ncbi.nlm.nih.gov/pubmed/31234141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-19-0104 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|